InsidersTradesSigma
Track the 百克生物 share price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 百克生物 has published 4 insider filings. Market capitalisation: €6bn. The latest transaction was reported on 27 February 2024 (Sale). Among the most active insiders: 朱昌林. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
百克生物 is a company focused on the healthcare and pharmaceutical sector, specializing in the development of biopharmaceutical solutions. It is listed on the Shanghai Stock Exchange (XSHG).